Brain stimulation treatment for treatment-resistant depression
Part of Mental health clinical trials.
This trial tests a personalized brain stimulation method called neuronavigated aiTBS for people with depression that hasn't improved with at least two prior treatments. The goal is to see if this therapy can safely and effectively reduce depressive symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a current diagnosis of major depressive disorder (unipolar, not bipolar).
- You have tried at least two different antidepressants or 12 sessions of therapy without success.
- Your depression is moderate to severe (a score >19 on a standard depression rating scale).
- Your antidepressant medication has been stable (same dose) for at least 6 weeks before starting the trial.
- You can attend treatment sessions for 15 days in a row (about 90 minutes each day) and complete evaluations.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain substances in the blood can help predict how well a type of brain stimulation called intermittent theta burst stimulation (iTBS) works for people whose depression hasn't improved with standard treatments. It may help doctors choose better treatments in the future.
This study tests an accelerated form of iTBS (a non-invasive brain stimulation technique) for depression that hasn't improved with antidepressant medications. The goal is to help people with major depression who haven't responded adequately to at least one antidepressant drug.
This study tests a type of brain stimulation called cTBS (continuous theta burst stimulation) applied to a specific part of the brain (the precuneus) to see if it helps with treatment-resistant depression. It aims to provide a new option for people who haven't found relief from standard treatments.
This study combines mindfulness practice with transcranial magnetic stimulation (TMS)—a non-invasive brain stimulation technique—to help people with depression that hasn't improved with antidepressant medications. The goal is to see if adding mindfulness to TMS improves how well the treatment works.
This study tests a type of brain stimulation (guided iTBS) to improve depression when standard antidepressant treatments haven’t helped. It also checks that the treatment is safe for people who can meet the study and scan safety requirements.
This study tests how a specific kind of brain stimulation (repetitive transcranial magnetic stimulation) works for people with depression that has not responded to standard treatments. If you qualify, it may help doctors understand the mechanism and improve options for treatment-resistant depression.
Hear when a new Treatment Resistant Depression (TRD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.